Provectus Biopharmaceuticals (PVCT) Stock Chart & Stock Price History $0.08 0.00 (-1.75%) As of 09:38 AM Eastern Add Compare Share Share Chart Stock AnalysisChartHeadlinesSEC FilingsShort InterestBuy This Stock Provectus Biopharmaceuticals Stock Price Performance The Provectus Biopharmaceuticals (PVCT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 24.88%, with a year-to-date return of -34.64%. In the past month, the stock has increased 12.14%, reflecting recent market activity. As of the latest close, Provectus Biopharmaceuticals traded at $0.08 with a market cap of $33.58 million and volume of 274,390 shares. Five years ago, the stock traded at $0.08, representing a 1.13% decrease over that period. At the time, it had a market cap of $31.75 million and a volume of 187,330 shares. Receive PVCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+3.70%1 Month Performance+12.14%3 Month Performance+2.61%Year-To-Date Performance-34.64%1 Year Performance-24.88%5 Year Performance-1.13% PVCT Stock Chart for Friday, October, 10, 2025 PVCT Chart by TradingView Provectus Biopharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/09/2025$0.08$0.08+3.77%$0.08$0.08274,390 shs$33.58 million10/08/2025$0.08$0.08-8.66%$0.08$0.0875,050 shs$32.36 million10/07/2025$0.08$0.08-0.71%$0.08$0.08200,900 shs$35.43 million10/06/2025$0.08$0.08+12.15%$0.08$0.0896,775 shs$35.68 million10/03/2025$0.08$0.08-0.66%$0.09$0.08107,635 shs$31.82 million10/02/2025$0.09$0.08-13.70%$0.08$0.07470,136 shs$32.03 million10/01/2025$0.09$0.09-0.79%$0.09$0.08171,992 shs$37.11 million09/30/2025$0.09$0.09-0.78%$0.09$0.09130,397 shs$37.41 million09/29/2025$0.09$0.09+2.63%$0.09$0.0871,142 shs$37.70 million09/26/2025$0.09$0.09-0.91%$0.09$0.08563,539 shs$36.74 million Get the Latest News and Ratings for PVCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 09/25/2025$0.07$0.09+31.64%$0.09$0.06901,347 shs$37.07 million09/24/2025$0.07$0.07-0.15%$0.07$0.0673,685 shs$28.16 million09/23/2025$0.07$0.07+3.23%$0.07$0.0778,684 shs$28.20 million09/22/2025$0.07$0.07$0.07$0.0635,450 shs$27.32 million09/19/2025$0.06$0.07+2.36%$0.07$0.06155,451 shs$27.32 million09/18/2025$0.07$0.06-6.62%$0.07$0.06217,351 shs$26.69 million09/17/2025$0.07$0.07-2.86%$0.07$0.06391,330 shs$28.58 million09/16/2025$0.07$0.07-5.02%$0.08$0.0736,854 shs$29.42 million09/15/2025$0.07$0.07+6.81%$0.07$0.07324,603 shs$30.98 million09/12/2025$0.07$0.07+1.32%$0.07$0.07234,091 shs$29.00 million09/11/2025$0.07$0.07-2.71%$0.07$0.0792,213 shs$28.62 million09/10/2025$0.07$0.07-2.78%$0.07$0.07303,896 shs$29.42 million09/09/2025$0.07$0.07-1.23%$0.07$0.07775,391 shs$30.26 million Related Companies IKT Stock Price Chart LFVN Stock Price Chart VIRI Stock Price Chart ACOG Stock Price Chart TIL Stock Price Chart SCLX Stock Price Chart ZNTL Stock Price Chart SPRO Stock Price Chart STTK Stock Price Chart SRZN Stock Price Chart Receive PVCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:PVCT) was last updated on 10/10/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"The Fed rate cut truth they don't want you to know The Fed's 25 basis point cut isn't just monetary policy…...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredElon Warns “America Is Broke”. Trump’s Plan Inside.For the everyday American who's worked hard to build their nest egg, Trump preserved a IRS loophole that allow...American Hartford Gold | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provectus Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Provectus Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
